Anxiety Disorders Recruiting Phase 4 Trials for Escitalopram (DB01175)

Also known as: Anxiety Disorder / Anxiety NOS

IndicationStatusPhase
DBCOND0027904 (Anxiety Disorders)Recruiting4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03522844Treatments for Anxiety: Meditation and EscitalopramTreatment